effect of different dual surfactant ratios by Capomacchia, Anthony C. et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=iphd20
Download by: [Lebanese American University Libraries] Date: 17 October 2017, At: 04:02
Pharmaceutical Development and Technology
ISSN: 1083-7450 (Print) 1097-9867 (Online) Journal homepage: http://www.tandfonline.com/loi/iphd20
Formulation parameters and release mechanism
of theophylline loaded ethyl cellulose
microspheres: effect of different dual surfactant
ratios
Mohan Thakare, Bridgette Israel, Solomon T. Garner, Hisham Ahmed,
Pamela Garner, Deborah Elder, James C. Price & Anthony C. Capomacchia
To cite this article: Mohan Thakare, Bridgette Israel, Solomon T. Garner, Hisham Ahmed, Pamela
Garner, Deborah Elder, James C. Price & Anthony C. Capomacchia (2013) Formulation parameters
and release mechanism of theophylline loaded ethyl cellulose microspheres: effect of different
dual surfactant ratios, Pharmaceutical Development and Technology, 18:5, 1213-1219, DOI:
10.3109/10837450.2011.620969
To link to this article:  http://dx.doi.org/10.3109/10837450.2011.620969
Published online: 12 Oct 2011.
Submit your article to this journal 
Article views: 114
View related articles 
Citing articles: 6 View citing articles 
1213
Introduction
Controlled release drug delivery systems are constructed 
to release a drug at a controlled rate for a predetermined 
time period ranging from hours to months.[1] Controlled 
drug delivery can be achieved by polymeric microspheres 
due to their ability to encapsulate a variety of drugs, bio-
compatibility, high bioavailability and sustained drug 
release characteristics.[2–4] Various formulation and pro-
cessing parameters affect microsphere characteristics 
and thus drug release. The design of microspheres by 
the emulsion-solvent evaporation method is affected by 
solvent evaporation temperature, emulsion mixing speed, 
surfactant chemical structure (s) and HLB, polymer type 
(s) and specifications, drug/polymer ratio, core drug par-
ticle size, and solvent (s) specifications. Judicious selec-
tion of these to control particle size is crucial in designing 
a controlled drug delivery system.[5]
Theophylline, a xanthine bronchodilator is employed 
to treat both chronic and acute asthma, but possesses a 
narrow therapeutic index; judicious control of its release 
from formulations must be assured. Owing to its narrow 
therapeutic index controlled release dosage forms must 
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be carefully constructed to assure optimum but not toxic 
release.[6–9] This makes it an excellent drug candidate to 
model controlled release since faulty formulation could 
cause the uncontrolled release of large amounts of theo-
phylline known as dose dumping and produce unwanted 
toxic effects.[10]
Theophylline cannot be loaded efficiently in micro-
spheres prepared with o/w emulsion systems, because a 
significant amount of drug is lost in the external phase.[11] 
Many factors affect the characteristics of microspheres 
such as type and molecular weight of the polymer, the 
core drug particle size, the drug to polymer ratio, drug 
solubility in the polymer, mixing intensity, and polymer 
phase viscosity.[3,12–14] There are reports that the emulsify-
ing agent (surfactant) also affects the characteristics of 
polymeric microspheres.[15,16]
Selecting a suitable surfactant as an emulsifier for a 
particular system often involves a great deal of experi-
mentation. The hydrophile-lipophile balance (HLB) 
system introduced by [17–19] can be used to select a single 
surfactant for optimum efficiency [20] or alternatively a low 
and high HLB surfactant can be blended together in order 
to stabilize emulsions at a particular HLB; this is known 
as the required or combined HLB (CHLB). For example, 
many investigators have reported on the application of a 
single surfactant like Span 80, Span 85, aluminum stear-
ate, or magnesium stearate for emulsion stabilization 
in the preparation of microspheres.[21–29] However, there 
is little literature on the subject of how dual surfactants 
affect a controlled release formulation physical proper-
ties and drug release mechanism.
Previous unreported data in this laboratory and lit-
erature reports demonstrated comparative changes in 
microsphere formulation properties upon using dual 
surfactants.[30,31] This could mean that formation of aggre-
gated microsphere structures in solutions utilizing mixed 
surfactants could be substantially different from those 
using a single surfactant. Moreover, drug release may 
follow a number of kinetic or empirical models, includ-
ing zero and first order, Higuchi square root, Korsmeyer–
Peppas, and Hixson–Crowell that may be altered through 
the use of mixed surfactants. The aim of this research 
was to study the comparative effects of dual surfactants 
(one high HLB and one low HLB) at different ratios and 
therefore different CHLBs versus single surfactants, on 
some physical parameters and drug release character-
istics of ethyl cellulose microspheres prepared with the 
emulsion-solvent evaporation method.
Methods
Materials
The following chemicals were used as obtained: ethyl cel-
lulose (Scientific Polymer Products, Ontario, New York; 
CAT# 460, cps 300); micronized (</= 10 µm) theophyl-
line, a gift from BASF; light mineral oil (Fisher Scientific, 
New Jersey); Span 65 (sorbitan tristearate), and Tween 
40 (polyethylene monopalmitate), from Ruger Chemical 
Company Inc., Irvington, NJ; methylene chloride (Fisher 
Scientific, NJ); acetone, monobasic potassium phosphate 
and sodium hydroxide (J.T. Baker, Phillipsburg, NJ).
Instruments
Stirrer (Lab Stirrer LR 400D, Yamato Scientific Company 
Ltd., Tokyo, Japan); Dissolution Apparatus II USP 
(Dissolution Test system 5100, Distek Inc., North 
Brunswick, NJ), Aquamate UV Spectrophotometer, 
Thermo Electron Corporation, Mercer’s Row, Cambridge, 
UK; Accumet 5 pH meter (Fisher Scientific, NJ); and, 
Precision Sieve Series, ATM Corp., Milwaukee Wis.; USP 
Standard sieve series for PSD (particle size distribution) 
studies.
Preparation of microspheres
Preparation of ethyl cellulose microspheres contain-
ing theophylline was accomplished by the emulsion-
solvent evaporation method in a 1 L tall glass beaker, in 
triplicate.[3,6,12–14] Acetone was selected as the hydrophilic 
solvent (internal phase) and mineral oil as the hydropho-
bic solvent (external phase) respectively, owing to reports 
stating that they facilitate microsphere formation;[32] and 
offer an advantage when scaling-up at the industrial 
level. Dual surfactants used in this process are presented 
in Table 1 with their respective HLBs and the ratios used 
to obtain the CHLBs. For preparation of all batches of 
microspheres, experimental conditions were kept iden-
tical. Light mineral oil (300 ml) containing the low HLB 
surfactant was used as the external or continuous phase 
(phase A). In a separate glass vessel the internal phase, 
100 ml of a 5 % (w/v) solution of ethyl cellulose in acetone 
was prepared (phase B). Micronized anhydrous theophyl-
line was dispersed in phase B to give a 33.3% theoretical 
drug loading–1 part theophylline (2.5 g) to 2 parts ethyl 
cellulose (5.0 g)). The entire contents of this vessel (phase 
B) were added into the glass beaker containing the solu-
tion of light mineral oil and low HLB surfactant (phase 
A) under vigorous agitation at 1200 rpm using three 
stacked 2.5 cm diameter propeller type blades. The total 
amount of surfactant used was 16 g: either 16 g of high 
HLB, Tween 40; or 16 g of low HLB, Span 65; or 16 g of 
their mixture = (xg of Tween 40 + yg of Span 65) for CHLB 
values between those of Tween 40 (HLB 15.6) and Span 
Table 1. The CHLB values for mixtures of Span 65 (S) and Tween 
40 (T) and HLB values for S and T, column 1; the ratio of S:T that 
produced the CHLB values, column 2; % theophylline loaded 
in the microsphere formulations, column 3; % encapsulation 
efficiency, column 4; and the Geometric Mean Diameter of 
microspheres formulated, column 5.
CHLB  
or HLB S:T ratio
% Drug  
loading
% Encapsulation 
efficiency GMD
ST 4.5 82:18 21.62 64.9 370
ST 5.5 77:23 21.90 65.8 355
ST 6.5 67:33 25.47 76.5 345
ST 7.5 60:40 22.52 67.7 375
S 2.1 100 S 22.58 67.8 380
T 15.6 100 T 31.70 95.2 690
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65 (HLB 2.1). Agitation was continued at 25°C until the 
acetone evaporated and the microspheres formed (12 
hours). Mineral oil was decanted from the microspheres 
deposited on the bottom of the vessel prior to their place-
ment on a vacuum filter and washed with mineral spirits 
(25 ml × 5 washes) to remove residual mineral oil. The 
clean microspheres were dried in an oven at 50°C over-
night and were free flowing and readily pourable.
Particle size distribution
The size distribution of theophylline microspheres was 
determined by passing the microspheres through a set 
of US standard sieves of range 90–710 μm. The aggregate 
sample was placed on the top sieve of largest size, covered, 
and then vibrated until no change in weight was observed 
for the microspheres collected in the sieves. Visual inspec-
tion assured that all particles retained on a sieve were 
larger than the sieve apertures. After sieving, the quantity 
of each fraction of particles was weighed. Particle size 
distribution and geometric mean diameters (GMD) were 
determined. GMD were obtained from log-probability 
plots of frequency versus log particle diameter.
Drug loading and encapsulation efficiency
The 355 μm fraction of each batch of ethyl cellulose 
microspheres was analyzed for theophylline loading. 
Drug loading was determined spectrophotometrically 
at 276.5 nm by placing accurately weighed samples, 100 
or 10 mg of microspheres (in triplicate) in 50 or 5.0 ml 
volumetric flasks, respectively and dissolving them in 
methylene chloride. Spectrophotometric interference 
from ethyl cellulose was not observed at this wavelength. 
An analytical curve of theophylline in methylene chlo-
ride prepared at concentrations 0.005–0.05% (w/v) was 
linear. Drug loading and encapsulation efficiency were 
calculated using the equations below:[20,33]
% drug loading
mg of drug in microspheres
mg of microsphere
=
s
100



 ×
% encapsulation efficiency
% drug loading
% theoretical dru
=
g loading
(33.3%)
In vitro dissolution studies and drug release
In vitro release studies of theophylline from ethyl cel-
lulose microspheres prepared with both single and dual 
surfactants were performed using a USP dissolution 
apparatus II (Distek Inc., New Jersey). The 355 μm fraction 
of each batch of microspheres was selected for evalua-
tion. Microsphere samples (100 mg) in triplicate for each 
batch were suspended in 900 ml of Simulated Intestinal 
Fluid, USP (Simulated Intestinal Fluid, pH 6.8 (SIF); USP 
26; KH2PO4 (6.805 g); NaOH (0.0896 g); deionized water 
to 1.0L) and no enzymes. The dissolution study was car-
ried out at 37 ± 0.5°C at 100 r.p.m for 12–24 hours until no 
further drug was leached from the microsphere samples. 
Three ml of samples were withdrawn, using a syringe 
fitted with a filter at needle end to exclude particulate 
material, at specific time intervals and replaced with 
fresh simulated intestinal fluid medium. Drug release 
was determined spectrophotometrically at 274 nm to 
obtain the dissolution profile and evaluate the mecha-
nism of drug release.
Data obtained from the in vitro drug release studies 
were fitted to zero order, Eqn. 1;[34] first order, Eqn. 2; 
[34] Higuchi square root model, Eqn. 3;[34–38] Korsmeyer-
Peppas, Eqn. 5;[34,39,40] and Hixson-Crowell, Eqn. 6[34,41] to 
evaluate the mechanism of drug release from ethyl cel-
lulose microspheres prepared with both single and dual 
surfactants.
1. zero order (M
t
 = M
o
 + k
o
t)
2. first order (ln M
t
 = ln M
o
 − k
1
t)
3. Higuchi square root (M
t
 = M
o
 − k
H-sqrt
 t1/2)
4. Korsmeyer-Peppas (M
t
/M
∞
 = k
KP
tn)
5. Hixson-Crowell (M
0
1/3 − M
t
1/3 = k
HC
t)
 Where, M
t
 = cumulative percentage drug released at time 
t; M
o
 = percentage drug dissolved at time 0; k = respective 
model rate constants.
SEM analysis of microspheres
The surface morphology of the formulated theophylline 
microspheres was observed by scanning electron micro-
scope (SEM) using a Zeiss model 1450 EP scanning elec-
tron microscope prior to dissolution. Microspheres were 
mounted onto metal multi-stubs using double-sided 
adhesive tape and SEM images were taken at specific 
magnifications after being gold coated.
Results and discussion
Geometric mean diameter (GMD) and particle size 
distribution (PSD)
Microspheres prepared with a single surfactant such as 
Span 65 (S2.1) or Tween 40 (T15.6) showed variation in the 
GMD, as shown in Table 1, with Span 65 showing a much 
lower GMD compared to those prepared with Tween 40. 
When the Span 65 and Tween 40 were employed as dual 
surfactants microsphere GMD was slightly smaller for 
CHLB 5.5 (ST5.5) and 6.5 (ST6.5), but almost equivalent 
for CHLB 4.5 (ST4.5) and 7.5 (ST7.5), to those prepared 
solely with Span 65 and much smaller than those pre-
pared solely with Tween 40. This may be attributed to the 
apparent formation of a strong droplet interfacial film 
during the emulsification process.[31] Surfactants in many 
cases maintain an emulsion with short-range repulsion 
or disjoining pressure that prevents droplet coalescence 
aiding smaller microsphere formation. This effect appar-
ently diminishes as CHLB values approach those of either 
Span 65 or Tween 40.
The particle size distribution (PSD) varied signifi-
cantly for microspheres prepared using single or dual 
surfactant microspheres (Figures 1 and 2). Microspheres 
prepared using the single surfactant Tween 40 (T15.6) 
displayed a skewed PSD with the majority of the par-
ticles in 710 µm fraction; while Span 65 (S2.1) showed 
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a skewed distribution with most particles in both the 
710 µm and 355 µm fractions (Figure 2). A bell-shaped 
PSD was observed when dual surfactants were used and 
the microspheres presented with most in the 355 range 
regardless of CHLB (Figure 1). The differences may be 
attributed to stabilization of the emulsion that must 
have occurred from using dual surfactants. Coalescence 
was most likely restricted at all CHLB values leading to 
a greater proportion of smaller microsphere particles 
relative to the PSD observed when single microspheres 
were used.[31]
Drug loading and encapsulation efficiency
Drug loading and encapsulation efficiency studies of the 
355 μm fractions of the microsphere batches revealed 
that there was no significant difference between micro-
spheres as surfactant CHLBs were changed with the 
exception of CHLB 6.5 (ST6.5 in Table 1). For micro-
spheres prepared at CHLB 6.5 drug loading was 12–19 
% greater than at all other CHLBs with a corresponding 
small decrease in GMD. The single surfactant Tween 40 
(T15.6) showed greater drug loading compared to dual 
surfactants; and may be due to coalescence as reflected 
by the creation of larger size microspheres, as well as an 
increased viscosity of the theophylline-ethyl cellulose 
dispersion comprising the emulsion internal phase. This 
view has been substantiated with reports that increased 
viscosity in the internal phase develops an emulsion with 
larger droplets.[13,14] Owing to this coarser emulsion larger 
microspheres are ultimately formed.
In vitro drug release
Figures 2–4 depict drug release profiles of the 355 µm 
fraction plotted according to zero order (Eqn. 1), and 
Higuchi square root (Eqn. 3); and Table 2 lists the rate 
constants, and correlation coefficients (R2) obtained from 
the respective plots. Plots generated from first order (Eqn. 
2), and Hixson Crowell (Eqn. 5) equations were also con-
structed and data tabulated in Table 2, but are not shown 
here. Plots generated from the Korsmeyer-Peppas model 
were also constructed; and Korsmeyer rate constants and 
n-values obtained, but are not reported here (Table 2) as 
discussed later.
The solvent evaporation method has been described 
as developing non-porous or relatively less porous 
Figure 1. Effect of different CHLB values on the particle size 
distribution for microspheres prepared with dual surfactants 
(Span 65 and Tween 40). 
Figure 2. Effect of HLB on particle size distribution for microspheres 
prepared with single surfactants (Span 65 and Tween 40). 
Figure 4. Drug release profile for dissolution according to the 
Higuchi square root kinetic model for microspheres prepared 
with varying ratios of dual surfactants Span 65 and Tween 40 (ST 
4.5–7.5), or with either Span 65 (S2.1) or Tween 40 (T15.6). 
Figure 3. Drug release profile for dissolution according to the zero 
order kinetic model for microspheres prepared with varying ratios 
of dual surfactants Span 65 and Tween 40 (ST 4.5–7.5), or with 
either Span 65 (S 2.1) or Tween 40 (T15.6). 
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microspheres in which the drug is distributed homog-
enously throughout the polymeric matrix; and release 
from such a matrix is either by erosion or by diffusion.[42] 
Furthermore, release was described as occurring in three 
stages, i.e. initial diffusional release from the superfi-
cial region of microsphere, followed by slower release 
by polymer hydrolysis and then finally a rapid release 
resulting from polymer erosion. The data presented 
here indicates excellent correlation for the dissolution 
rate constants using Higuchi’s square root model and 
implies diffusional drug release for all single and dual 
surfactant microspheres, except ST 7.5 (Table 2). Drug 
release is apparently not dependent on the chemical or 
physical erosion of the polymer as seen from the poor 
correspondence to the Hixson Crowell model (Table 2). 
However, this point indicates the reduced utility for the 
Higuchi model when used to describe drug release in 
hydrophobic matrix systems, since neither matrix ero-
sion nor hydration and swelling are considered by the 
model.[43,44] For this reason, the dissolution data pre-
sented here was initially recast in the Korsmeyer–Peppas 
equation. However, upon close review of the work of 
Ritger and Peppas it became clear that this approach 
could only be used to describe drug release from non-
swellable polymeric matrices from a monodisperse 
sample.[40] Since the microspheres prepared here were a 
polydisperse sample the model could not be utilized as 
explained below.
The n values for the Korsmeyer–Peppas model have 
been shown to be dependent on the range and shape 
of the particle size distribution.[40] For a monodisperse 
sample limiting values of n have been established for 
non-swelling spherical particles, where: n = 0.43 indi-
cates Fickian diffusion; 0.43 < n < 0.85 indicates anoma-
lous (non-Fickian diffusion); and n = 1.0 indicates zero 
order release.[40] Values of n falling within the above 
ranges shed light on the drug release mechanism, e.g. 
Fickian diffusion. In Figures 1 and 2, the 355 µm frac-
tion was employed for dissolution studies, and is a 
polydisperse microsphere sample with particle sizes 
ranging from 355 µm–594 µm; therefore the limiting 
values for n theoretically calculated for a monodisperse 
sample cannot be reliably used as limits to identify 
the release mechanism for this sample of particles. 
The explanation for this is that for any collection of 
particles, those particles smaller than the mean size 
release drug faster than particles larger than the mean, 
thus skewing the curve and evaluation of n.[40] For the 
current study, particle size distribution varies compara-
tively between formulations, for example ST4.5 versus 
ST5.5, and also between triplicate batches within each 
formulation selected, e.g. within batches of ST4.5. This 
makes their use impractical to identify a drug release 
mechanism using the Korsmeyer–Peppas model for 
the microspheres examined here, since the limiting 
n values for each mechanism in the polydisperse  sample 
is unknown.
The comparatively poor fit for the first order model 
and the excellent fit with the Higuchi model, support the 
formation of a monolithic microsphere matrix system 
that releases drug by Fickian diffusion for all formula-
tions except ST7.5. The relatively good fit for the zero 
order model seen in formulations ST4.5 and S2.1 may 
indicate the existence of multiple drug release mecha-
nisms for these two formulations prepared at the lower 
end of the HLB scale.
Scanning electron microscopy (SEM) analysis
The SEM micrographs of microspheres prepared from 
single and dual surfactants are shown in Figure 5. Use 
of single and dual surfactants at all CHLBs affected 
microsphere morphology and resulted in free flowing 
particles that were mostly spherical to slightly oblong. 
Formulations A, B. D, and E in Figure 5 presented with 
smooth to slightly rough surfaces depending on the sur-
factant system used. Microsphere formulations C and 
F presented with comparative increased roughness in 
surface morphology, which may be related to changes in 
drug release only for the latter, but not the former.
Conclusions
The use of dual surfactants for the preparation of micro-
spheres is an inadequately studied research area that 
offers another means to modulate particle size and drug 
release. For the current study microspheres prepared 
with surfactant ratios of Span 65: Tween 40 between 
3:1 and 2:1 provided the best control of size and drug 
release.
Dissolution data reported here followed the Higuchi 
model for drug release and supports the formation of a 
monolithic microsphere matrix that releases drug by 
Fickian diffusion for most dual and single surfactant for-
mulations examined.
Table 2. Dissolution rate constants, R2 and n values for the tested formulations obtained from the kinetic models.
CHLB or HLB
Zero order rate  
constant, K0
Higuchi, sqrt rate  
constant, KH-sqrt
First orderrate  
const., K1
Hixson–Crowell 
rate constant, KHC
ST 4.5 7.92 R2 0.9813 31.02 R2 0.9893 0.2441 R2 0.9146 0.1984 R2 0.9322
ST 5.5 7.53 R2 0.9635 28.14 R2 0.998 0.3301 R2 0.9134 0.1678 R2 0.8697
ST 6.5 7.07 R2 0.9688 30.26 R2 0.9905 0.2804 R2 0.8628 0.1529 R2 0.9095
ST 7.5 3.62 R2 0.697 15.25 R2 0.8113 0.137 R2 0.7988 0.0728 R2 0.651
S 2.1 5.98 R2 0.9807 22.28 R2 0.985 0.2263 R2 0.9687 0.1316 R2 0.9461
T 15.6 8.03 R2 0.9734 30.77 R2 0.9847 0.165 R2 0.9555 0.1957 R2 0.9194
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